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The Iga/Igb Heterodimer on m-Negative ProB
Cells Is Competent for Transducing Signals
to Induce Early B Cell Differentiation
for a component of preBCR, either the membrane form
of m heavy chain or the l5 protein (Kitamura et al., 1991,
1992). In these knockout mice, B cell development was
found to be severely impaired at the transition from the
proB cell stage to the large preB cell stage, resulting in
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Identification of molecules involved in preBCR signal-tected on the surface of m-negative proB cell lines in
ing is essential for elucidating the mechanism by whichassociation with calnexin. The cross-linking of Igb on
the preBCR controls those events in early B cell develop-proB cells freshly isolated from bone marrow of re-
ment. However, the biochemical study of the preBCRcombination activating gene (RAG)-2±deficient mice
signaling pathway is far behind that of B cell receptorinduced a rapid and transient tyrosine-phosphoryla-
(BCR) for several reseasons. First of all, the extremelytion of Iga as well as an array of intracellular proteins
low level of preBCR surface expression has hamperedincluding Syk, PI3-kinase, Vav, and SLP-76. It also elic-
biochemical studies (Brouns et al., 1993; Lassoued etited the phosphorylation and activation of a MAP ki-
al., 1993; Karasuyama et al., 1994; Winkler et al., 1995).nase ERK but not JNK/SAPK or p38. When RAG-2±
Moreover, there was, so far, no appropriate system us-deficient mice were treated with anti-Igb monoclonal
ing nontransformed cells in which early B cell differentia-antibody, developmentally arrested proB cells were
tion could be induced in vivo and ex vivo. In contrast,induced to differentiate to the small preB cell stage
in the case of T cells, fetal thymus organ culture hasas observed when the m transgene was expressed in
been used successfully as a powerful tool to study earlyRAG-2±deficient mice. Thus, the cross-linking of Igb
T cell development (reviewed by Jenkinson and Owen,on proB cells appears to elicit differentiation signals
1990; DeLuca et al., 1995). Though the use of Abelsonanalogous to those delivered by the preB cell receptor
murine leukemia virus±transformed mouse preB cellin normal B cell development.
lines and human leukemia preB cell lines has brought
tremendous progress in our understanding of immuno-
Introduction globulin (Ig) gene rearrangements (Alt et al., 1981; re-
viewed by Rosenberg, 1994), they generally do not seem
The discovery of preB cell receptor (preBCR) has cast proper materials to analyze the differentiation signals
a new light upon the significance of m heavy chain ex- of preBCR. First of all, they appear frozen in a given
pressed at the preB cell stage of B cell development differentiation stage so that it would not be easy to force
where conventional light chain is not yet expressed (Sa- them to differentiate further. In this regard, so far only
kaguchi and Melchers, 1986; Kudo and Melchers, 1987; one successful study has been reported, in that cross-
Pillai and Baltimore, 1987, 1988). At this stage, m heavy linking of truncated m heavy chain expressed on trans-
chain associates with VpreB/l5 surrogate light chain in formed proB cell lines induced Vk gene rearrangements
place of conventional light chain to form preBCR (Kara- (Tsubata et al., 1992). Second, in vitro transformed cell
suyama et al., 1990, 1994; Tsubata and Reth, 1990; Las- lines exhibit a relatively high background of kinase activity
soued et al., 1993). The critical role of preBCR in B cell even without any stimulation when analyzed for the phos-
development was illuminated by creating mice deficient phorylation of intracellular proteins. This could be due to
the transformation of cells with the v-abl oncogene of the
virus (reviewed by Baltimore et al., 1979). Alternatively,‖To whom correspondence should be addressed.
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preBCR might be autonomously active independent of
external ligand as proposed by Pillai and his colleagues
(Aoki et al., 1994a, 1994b). In either case, the high basal
kinase activity in the cell lines severely hampers the analy-
sis of signaling elicited by cross-linking of preBCR.
It has been reported that the preBCR on preB cell
lines could transduce signals to increase intracellular
free Ca21 to some extent upon cross-linking (Takemori
et al., 1990; Misener et al., 1991; Nomura et al., 1991;
Nakamura et al., 1993). Recent studies demonstrated
that Ca21 mobilization and up-regulation of CD69 sur-
face expression could also be induced in vitro by coliga-
tion of preBCR and CD19 and by cross-linking preBCR
itself, respectively, on bone marrow preB cells from m
heavy chain transgenic RAG-deficient mice (Krop et al.,
1996; Young et al., 1997). However, physiological rele-
vance of these observations in terms of normal B cell
differentiation remains unclear.
In the present study, to overcome the limitation of in
vitro cell lines for studying the preBCR signaling path-
way, we have established a novel system using bone
marrow proB cells stimulated in vivo and ex vivo with a
unique anti-mouse Igb monoclonal antibody (MAb). In this
system, the Iga/Igb-mediated signal elicited the transient
and synchronous differentiationof proB cells to small preB
cells in vivo and a series of intracellular biochemical
changes detectable ex vivo. We show that this is a supe-
rior approach to analyze successive events elicited by
the Iga/Igb-mediated preBCR signal transduction.
Results Figure 1. The Expression of Igb on the Surface of ProB Cells in the
Absence of m Heavy Chain
ProB Cells Express Iga/Igb Heterodimer (A) ProB cell lines (63-12, 38B9) as well as preB (NFS5.3) and imma-
ture B (WEHI231) cell lines were stained with biotin-conjugatedin Association with Calnexin on Their
MAbs plus PE-SA. The fluorescence intensity of the stained cellsSurface Even in the Absence
was analyzed by flow cytometer. Thin dotted line histogram, controlof PreBCR and BCR
staining with normal hamster or rat IgG; thick solid line histogram,
In our previous report (Koyama et al., 1997), we demon- staining with MAb specific to either Igb, l5, or m heavy chain.
strated the surface expression of the Iga/Igb hetero- (B) Bone marrow cells from RAG-2±deficient mice were analyzed
dimer not only on preB and B cells butalso on m-negative for the expression of Igb on the surface as well as in the cytoplasm.
In the left panel, cells were surface stained with FITC±anti-CD45RproB cells as shown in Figure 1. Since the heterodimer
(B220) together with either biotin±anti-Igb (HM79) or biotin-normalon preB and B cells has been shown to be in association
hamster IgG plus PE-SA. Igb staining (thick line) and control stainingwith the m heavy chain, we first investigated a mole-
(thin line) of CD45R (B220)1 bone marrow cells are overlayed in the
cule(s) associated with the heterodimer in place of the histogram. In the right panel, cells were stained with PE±anti-CD45R
m heavy chain on proB cell lines 38B9 and 63-12. Cell (B220) on the surface, followed by cytoplasmic staining with biotin±
surface iodination followed by immunoprecipitation with anti-Igb (HM79) plus Cy-Chrome-SA. Two-color analysis of cells
present in the lymphocyte gate is shown.anti-Iga antibody identified a major band with the appar-
ent molecular weight of ~95 kDa as coprecipitated with
the Iga/Igb heterodimer (Figure 2A). When cell lysates
for immunoprecipitation were prepared by using the the 95 kDa molecule as calnexin. To analyze the Iga/
Igb complexes expressed only on the cell surface butharsher detergent Nonidet P-40 (NP-40) instead of dig-
itonin, the association of this molecule became less not in the cytoplasm, 38B9 cells were first incubated
with either anti-Iga polyclonal antibody or anti-Igb MAbevident (data not shown). Furthermore, the treatment of
N-glycosidase F did not change the size of the molecule, HM79, and then unbound antibodies were washed away
before cell lysates were prepared. The immune com-ruling out the possibility that the 95 kDa molecule was
the N-linked glycoprotein CD19 expressed on B-lineage plexes in lysates were trapped on protein A±Sepharose
beads and subjected to SDS-polyacrylamide gel elec-cells (data not shown).
These characteristics of the 95 kDa molecule were in trophoresis (SDS-PAGE). The subsequent Western blot
analysis with anti-calnexin antibody revealed that theaccord with those of calnexin, which has recently been
shown to associatewith the CD3 complex on thesurface 95 kDa surface molecule coprecipitated with the Iga/
Igb heterodimer was indeed calnexin (Figure 2B). Theof T cell receptor (TCR)-negative proT cells (Wiest et al.,
1995). We therefore examined the possible identity of same result was obtained by using another proB cell
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the Iga/Igb heterodimer with the anti-Igb MAb HM79.
However, it turned out that many proteins were already
tyrosine-phosphorylated to a great extent in these cell
lines even before the cross-linking, most likely due to
the transformation of cells with Abelson murine leukemia
virus (data not shown). To avoid this undesirable high
background in the analysis of signal transduction, as a
source of proB cells we next utilized bone marrow cells
freshly isolated from RAG-2±deficient mice where B cell
development was trapped at the proB cell stage owing
to the inability to initiate the recombination of Ig genes
(Shinkai et al., 1992).
The cross-linking of Igb on RAG-22/2 bone marrow
cells with biotin-HM79 (hamster anti-mouse Igb MAb)
and streptavidin induced a rapid and transient tyrosine-
Figure 2. Characterization of Molecules Associated with the Iga/ phosphorylation of a number of proteins (Figure 3), even
Igb Heterodimer on ProB Cells though the level of Igb surface expression on bone mar-
(A) 38B9 proB cells were surface labeled with 125I. Digitonin-lysates row proB cells was considerably lower than that on the
of cells (3 3 107 cells) were incubated with either rabbit anti-Iga transformed proB cell lines (Figure 1B). The treatment
antiserum or normal rabbit serum as control. Immunoprecipitated of the cells with irrelevant hamster antibodies (normal
proteins were analyzed by SDS-PAGE and autoradiography. The
hamster IgG) didnot elicit such phosphorylation, indicat-position of Iga, Igb, and a band of a ~95 kDa molecule are indicated
ing that the observed phosphorylation was specific toat the right.
HM79 but not due to nonspecific effect of hamster anti-(B) 38B9 proB cells (5 3 107 cells) were incubated with either anti-
bodies (Figure 3). Since essentially all of the Igb-produc-Iga antiserum, anti-Igb MAb (HM79), or normal rabbit serum (con-
trol). After unbound antibodies were washed away, cells were lysed ing cells inbone marrow expressed theB-lineage marker
with digitonin lysis buffer. Cell lysates were incubated with protein CD45R(B220) as shown in Figure 1B, the observed phos-
A±Sepharose beads to collect the cell surface protein complexes phorylation induced by the cross-linking of Igb in the
bound to the antibodies. The protein complexes were analyzed by
bone marrow population was exclusively from proBSDS-PAGE and Western blot with anti-calnexin antibody. The posi-
cells, but not from other lineage cells. The spectrumtion of calnexin (CXN) is indicated by arrow head.
of phosphorylated proteins in bone marrow proB cells(C) 38B9 proB cells were lysed with either digitonin- or NP-40±lysis
buffer. Lysates of 1 3 107 cells were reacted with the antibody appeared distinct from that in splenic B cells stimulated
specific to either Iga, Igb, CD3e, MHC class I, or normal rabbit serum in the same way (Figure 3). Particularly, the species with
(control). The immunoprecipitates were subjected to the in vitro apparent molecularweight of 35±40 kDa were prominent
kinase assay. The phosphorylated proteins were analyzed by SDS- in proB cells but not in splenic B cells. In contrast, the
PAGE and autoradiography.
phosphoproteins of 130 and 180 kDa were evident in
splenic B cells but not in proB cells.
To identify each species of tyrosine-phosphorylated
line 63±12 which was derived from RAG-2±deficient
proteins in proB cells, immunoprecipitation with avail-
mice (data not shown).
able antibodies specific to the known signaling mole-
cules was performed with cell lysates prepared at vari-
Cross-Linking of Igb on ProB Cells Induces ous time points after the Igb cross-linking, followed by
the Activation of Tyrosine- and Serine/ Western blot analysis with anti-phosphotyrosine anti-
Threonine Kinases body. A number of proteins were identified as inducibly
When the Iga/Igb complexes precipitated from 38B9 phosphorylated on tyrosine residue by Igb cross-linking
cells with the specific antibodies were subjected to the as shown in the left panel of Figure 3: p110 catalytic
in vitro kinase assay, a number of proteins distinct from subunit of PI3-kinase (110 kDa), Vav (95 kDa), SLP-76 (76
the Iga/Igb/calnexin complex were found to be phos- kDa), Syk (72 kDa), extracellular signal-regulated protein
phorylated (Figure 2C). This was observed only when kinase 1 (ERK1) (44 kDa), and Iga (32 kDa). The tyrosine-
the Iga/Igb immunoprecipitates were prepared from dig- phosphorylation of all these proteins was very rapid and
itonin lysates but not from NP-40 lysates. Furthermore, peaked at 0.5 or 1 min after the cross-linking of Igb.
the immunoprecipitates with irrelevant antibodies such Since ERK1 is a MAP kinase, an important component
as anti-CD3e and anti-major histocompatibility complex of the MAP kinase cascade involved in the signal trans-
(MHC) class I MAbs did not show phosphorylation activ- duction via various kinds of receptors, we next examined
ity. The same results were obtained with 63-12 cells (data whether the three known MAP kinase cascades were
not shown). Since neither the Iga/Igb heterodimer nor activated by the cross-linking of Igb on proB cells.
calnexin possesses any kinase activity, these results Among the three MAP kinase isoforms (ERK, c-Jun
indicated that the Iga/Igb/calnexin complexes expressed N-terminal kinase [JNK]/stress-activated protein kinase
in proB cells associated with a molecule(s) carrying ki- [SAPK], and p38), only ERK was found to be activated by
nase activity. up to 10-fold in its kinase activity with the peak activity
Thus, the Iga/Igb heterodimer on proB cells appeared mesured at 1 min after cross-linking (Figure 4A and 4B).
to have potential to transduce signals, not unlike that Taken together, we concluded that the Iga/Igb hetero-
associated with preBCR and BCR. Therefore, we tried dimer expressed on bone marrow proB cells was com-
petent for transducing signals across the cell membraneto deliver signals in the proB cell lines by cross-linking
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Figure 3. Cross-Linking of Igb on RAG-2±
Deficient ProB Cells In Vitro Induces a Rapid
Tyrosine-Phosphorylation of a Number of
Proteins
Bone marrow cells from RAG-2±deficient
mice andspleen cells from BALB/c mice were
preincubated with biotin-conjugated anti-Igb
MAb HM79 or irrelevant antibody (normal
hamster IgG) for 5 min on ice, followed by the
addition of streptavidin and the incubation at
378C for 0, 0.5, 1, or 5 min. The cell number
was adjusted to 5 3 106 for bone marrow
samples and 1.5 3 106 for spleen samples so
that both samples contained a comparable
number of CD45R (B220)1 Igb1 cells (~3 3
105 cells/sample). The antibody-treated cells
were lysed with NP-40 lysis buffer, and tyro-
sine-phosphorylated proteins in cell lysates
were immunoprecipitated with anti-phosphotyrosine MAb (4G10)-conjugated beads. The immunoprecipitates were subjected to SDS-PAGE
(5±20% gel), followed by Western blot analysis with 4G10. Identification of each phosphoprotein was performed by the immunoprecipitation
with antibodies specific to signaling molecules as shown in left panel, followed by Western blot analysis with 4G10.
to activate intracellular kinases even prior to its incorpo- marrow proB cells (the profile of CD25 surface expres-
sion is shown in Figure 6B, left panels) while it inducedration into the preBCR complex.
the expression of CD4 and CD8 on thymocytes (Figure
6B, right panels) as reported previously (Jacobs et al.,
1994; Shinkai and Alt, 1994). However, the treatment ofB Cell Differentiation Is Induced in RAG-2±Deficient
RAG-2±deficient mice with HM79 had no effect on theirMice When Treated with Anti-Igb MAb
thymocytes (Figure 6B, right panels).The results obtained from the ex vivo experiments raised
The phenotypic changes on proB cells in the HM79-the question as to whether the signals transduced from
treated RAG-2±deficient mice were comparable to thosethe Iga/Igb heterodimer could induce any change on
observed when the functionally rearranged m heavythe phenotype of proB cells in vivo. To address this
chain gene was expressed as the transgene in RAG-question, RAG-2±deficient mice were treated by a single
2±deficient mice (Figure 5 bottom row; Spanopoulou etinjection of 1 mg of anti-Igb MAb HM79, and their bone
al., 1994; Young et al., 1994). In both mice, the inductionmarrow cells were isolated and analyzed by flow cytom-
of CD23 expression, a marker of immature and mature
etry at various time points after injection. Figure 5 shows
B cells, was not detected on CD45R(B220)1 cells (data
representative results obtained from bone marrow cells
not shown). The smaller-sized cell population was greatly
on day 8 after injection. The expression of CD25(Tac),
increased among CD45R(B220)1 cells in the HM79-
BP-1 and CD2 on CD45R(B220)1 cells was up-regulated, treated mice as observed in the m-transgenic mice (Fig-
whereas that of CD117(c-kit), CD43(S7), and l5 was ure 6A). The smaller cells werealmost exclusively CD251
down-regulated in the treated mice as compared with (Figure 6A). Since the proportion of CD45R(B220)1 cells
the untreated mice (Figure 5, upper and middle rows). in bone marrow of the treated mice was significantly
These phenotypic changes should not be due to the higher than that of untreated mice (Figure 6A), we exam-
nonspecific effect of hamster antibodies injected, be- ined theabsolute number of CD45R(B220)1 cells in bone
cause the injection of another hamster antibody 2C11, marrow from the treated mice at various time points
after the injection. A representative result of the kineticsanti-CD3e MAb, did not induce any change on bone
Figure 4. MAP Kinase ERK Is Activated by
Cross-Linking of Igb on RAG-2±Deficient
ProB Cells In Vitro
In (A), RAG-2±deficient bone marrow cells
were treated with biotin±anti-Igb MAb HM79
plus SA for 0, 1, or 5 min as described in
Figure 3, whereas in (B) for 0, 0.5, 1, 2, 5, or 10
min. Cell lysates were prepared as in Figure 3
and incubated with antibodies specific to
three MAP kinase isoforms, ERK1, JNK1, or
p38. Immunoprecipitates were subjected to
the in vitro kinase assay with substrates: MBP
for ERK1, c-Jun/GST for JNK1, and ATF2/
GST forp38. Phosphorylated substrates were
analyzed by SDS-PAGE and autoradiography.
(B) The kinetics of ERK1 activity was shown. The intensity of phosphorylation at the indicated time was quantified by measuring the radioactivity
of MBP with the image analyzer (lower panel). The arbitrary unit of kinase activity was calculated as the ratio of the phosphorylation of MBP
at each time point versus at time 0 (upper panel).
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Figure 5. The In Vivo Treatment with Anti-Igb
MAb Induced Phenotypic Changes of Bone
Marrow proB Cells in RAG-2±Deficient Mice
RAG-2±deficientmice (10±13 weeks old) were
injected intraperitoneally with 1 mg of anti-
Igb MAb HM79. On day 8 post-injection, bone
marrow cells were stained with FITC±anti-
CD45R (B220) and biotin-conjugated anti-
bodies specific to either CD25 (Tac), BP-1,
CD2, CD117 (c-kit), CD43 (S7), or l5 plus
PE-SA. Cells present in the lymphocyte gate
definedby light scatter wereanalyzed by two-
color flow cytometry (middle row). Bone mar-
row cells from age-matched RAG-2±deficient
mice (RAG2/2) with or without the m transgene
(mTG) were analyzed in parallel (bottom and
upper row, respectively). Datashown are rep-
resentative of six repeated analyses.
is shown in Figure 7. After the latent period of 4 days, Igb complex on proB cells was fully competent for trans-
ducing signals to induce B cell differentiation, whenthe cell number increased up to ~5±6 times at the peak
on day 6, then declined gradually and returned to the directly cross-linked with the antibody. This indicates
that the Iga/Igb heterodimer is an important componentbasal level by day 12. The maximal cell number was
comparable to the number of CD45R(B220)1 cells in of the preBCR complex to deliver differentiation signals.
Consistent with this, B cell developmentwas found com-bone marrow of the m-transgenic RAG-2±deficient mice.
The proportion of CD251 cells amongthe CD45R(B220)1 pletely blocked at the proB cell stage in Igb-deficient
mice (Gong and Nussenzweig, 1996) and partially inhib-cells showed similar kinetics (Figure 7B).
Thus, the phenotypic changes of proB cells analyzed ited in Iga cytoplasmic tail-deficient mice (Torres et al.,
1996). Our results are also in accord with the observa-in the HM79-treated RAG-2±deficient mice were indistin-
guishable from those observed when the m-transgene tions that the expression of a transgene encoding either
m heavy chain/Igb tail or m heavy chain/Iga tail chimerawas expressed in RAG-2±deficient mice. These results
indicated that the cross-linking of Igb on proB cells promoted B cell differentiation in RAG-1±deficient mice
(Papavasiliou et al., 1995a, 1995b). One advantage oftransduced signals to induce their differentiation to the
stage corresponding to the small preB cell stage in nor- our system over this transgenic system is that the elicita-
tion of transient and synchronous responses of proBmal B cell development.
cells by anti-Igb MAb allows us to examine the kinetics
of each process along the differentiation pathway, inDiscussion
contrast to the constitutive activation of preBCR in the
transgenic system.Cross-Linking of Igb on proB Cells Mimics
Since proB cells already express VpreB/l5 surrogatethe preBCR Signaling to Induce Early B
light chain (Misener et al., 1991; Karasuyama et al., 1994;Cell Differentiation
Meffre et al., 1996; Sanz and de la Hera, 1996) as wellWe have established in the present study a novel system
as the Iga/Igb complex with all modules necessary forthat provides a superior way to analyze the signal trans-
signal transduction as demonstrated in the presentduction of the preBCR by using nontransformed cells.
study, m heavy chain appears to be the only missingIn this system, the cross-linking of Igb on RAG-22/2 bone
component to make the functional preBCR. This shouldmarrow proB cells with specific MAb mimics the signal
be notable when we consider the functional role ofthat is normally transduced via preBCR. This interpreta-
preBCR in early B cell development. As soon as proBtion is based on the finding that the cross-linking of Igb
cells succeed in productive rearrangement of m heavyinduced early B cell differentiation in bone marrow of
chain gene, the produced m heavy chain associates withRAG-2±deficient mice as observed when the m trans-
the other components to form the preBCR complexgene was introduced into RAG-2±deficient mice in order
competent to deliver signals. This prompt formation ofto express m heavy chain to form preBCR. The differenti-
and signaling from preBCR would ensure prompt allelication induced by the cross-linking was characterized by
exclusion in the m heavy chain loci.the following features: changes in surface phenotype of
CD45R(B220)1 cells, that is, up-regulation of CD2, CD25
and BP-1 in parallel with down-regulation of CD43, Biochemical Events in the Iga/Igb-Mediated
preBCR Signaling PathwayCD117, and surrogate light chain; expansion of B lineage
compartment in bone marrow; and accumulation of B cell differentiation induced by Igb cross-linking is rem-
iniscent of the T cell differentiation induced by CD3smaller CD45R(B220)1 cells with CD25 expression. All
of these are characteristic changes observed at the proB cross-linking in RAG2/2 thymocytes (Jacobs et al., 1994;
Shinkai and Alt, 1994; Levelt et al., 1995). The cross-to preB cell transition in normal B cell development
(Hardy et al., 1991; Karasuyama et al., 1994; Rolink et linking of CD3 on developmentally arrested CD42CD82
thymocytes leads to their differentiation to CD41CD81al., 1994; Young et al., 1994).
The present study clearly demonstrated that the Iga/ thymocytes, concomitant with expansion of cellularity
Immunity
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Figure 7. Transient Expansion of CD45R (B220)1 CD25 (Tac)1 Cells
in Bone Marrow of RAG-2±deficient Mice Treated with Anti-Igb MAb
RAG-2±deficientmice (10±13 weeks old) were injected intraperitone-
ally with 1 mg of anti-Igb MAb HM79. On day 4, 6, 8, 10, or 12 post-
injection, bone marrow cells prepared from a pair of femurs and
tibias of these mice were counted and stainedwith FITC±anti-CD45R
(B220) MAb and biotin±anti-CD25 (Tac) MAb plus PE-SA.
(A) shows the kinetics of number of CD45R (B220)1 cells in the bone
marrow.
(B) shows the kinetics of the percentage of CD25 (Tac)1 cells among
CD45R (B220)1 B lineage cells in the bone marrow. Representative
data from six repeated analyses are shown.
marrow proB cells but not in splenic B cells, whereas
that of 130 and 180 kDa proteins was evident in splenic
B cells but not in bone marrow proB cells. This indicates
that preBCR and BCR may activate distinct signaling
modules besides common ones even though both re-
ceptors utilize the Iga/Igb heterodimer as a common
signal transducer. Indeed, no significant Ca21 flux was
detected upon cross-linking of Igb on bone marrow proB
cells, in contrast to the prominent Ca21 flux in splenic
Figure 6. The In Vivo Treatment with Anti-Igb MAb Induced the Ap- B cells treated with the anti-Igb MAb (unpublished ob-
pearance of Small PreB-like Cells in Bone Marrow While Leaving servation). We are currently characterizing the ~35±40Thymocytes Unchanged
kDa phosphoprotein detected only in proB cells.
(A) CD45R (B220)1 cells in bone marrow from the mice shown in
Syk, a tyrosine kinase of the Syk/ZAP-70 family (Tani-Figure 5 were further analyzed for their cell size in conjunction with
guchi et al., 1991; reviewed by van Oers and Weiss,the expression of CD25. The proportion of CD45R (B220)1 cells in
1995), was found tyrosine-phosphorylated very rapidlythe lymphocyte gate (left column) and their size defined by forward
scatter (center column)are shown. The cell size of CD251 andCD252 and transiently by cross-linking of Igb on bone marrow
subpopulations among CD45R (B220)1 cells in the anti±Igb-treated proB cells. This strongly suggests that Syk is a compo-
RAG-2±deficient mice is shown in the right column. nent of the preBCR signaling cascade. Consistent with
(B) RAG-2±deficient mice were injected intraperitoneally with 1 mg
this, hematopoietic stem cells derived from Syk-defi-of either anti-Igb MAb HM79 or anti-CD3e MAb 2C11. On day 8
cient mice showed severe impairment in early B cellpost-injection, bone marrow cells were stained with FITC±anti-
development analogous to that observed in l5-deficientCD45R (B220) MAb and biotin±anti-CD25 (Tac) MAb (left column),
while thymocytes were stained with FITC±anti-CD8 and biotin±anti- mice (Cheng et al., 1995; Turner et al., 1995). In a study
CD4 mAbs (right column).Biotin-conjugated reagents were revealed with human preB and B cell lines, it was reported that
by PE-SA. Bone marrow cells and thymocytes from untreated RAG- no detectable phosphorylation and activation of Syk
2±deficient mice were analyzed in parallel (upper row). The two-
was induced by preBCR cross-linking incontrast to BCRcolor analyses of cells within the lymphocyte gate are shown.
cross-linking (Kuwahara et al., 1996). It is presently un-
clear whether this reflects a species difference in the
in thymus of RAG-deficient mice. This is thought to functional role of Syk in early B cell development. BCR
mimic the signal that is normally delivered via preTCR cross-linking has been shown to induce the phosphory-
(Levelt et al., 1993a,1993b). However, detailed biochem- lation and activation of Lyn, a tyrosine kinase of the Src
ical analysis of intracellular events elicited by CD3 cross- family (Burkhardt et al., 1991; Yamanashi et al., 1991,
linking has not been reported so far to our knowledge. 1992). In contrast to this, we detected no increase or
In the present study, we clarified that the cross-linking of only a slight increase in tyrosine-phosphorylation of Lyn
Igb on proB cells induces a rapid and transient tyrosine- by Igb cross-linking on proB cells (unpublished observa-
phosphorylation of Iga as well as an array of intracellular tion), suggesting a minor role of Lyn in the preBCR sig-
proteins. The profile of those phosphorylated proteins naling. This appears consistent with the observation that
was clearly distinct from that observed in splenic mature Lyn-deficient mice showed normal B cell development
B cells stimulated by the same MAb. The tyrosine-phos- despite severe impairment of BCR signaling in mature
B cells (Hibbs et al., 1995; Nishizumi et al., 1995).phorylation of ~35±40 kDa proteins was evident in bone
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Vav, a guanine nucleotide exchange factor for Rac-1 the involvement of MAP kinase cascade in preBCR sig-
naling. The MAP kinases are serine/threonine protein(Crespo et al., 1997; reviewed by Collins et al., 1997), has
been shown to associate with tyrosine-phosphorylated kinases that are activated by many kinds of receptors
and have been implicated in the control of expressionSyk through its SH2 domain and to be tyrosine-phos-
phorylated by activated Syk in BCR-stimulated B cells of genes essential for cellular processes such as cell
proliferation, differentiation, and stress responses (re-(Deckert et al., 1996). This interaction of Syk and Vav may
take place also in the preBCR signaling pathway, since viewed by Moriguchi et al., 1996; Su and Karin, 1996).
Though there are three known MAP kinase isoformswe observed a parallel tyrosine-phosphorylation of Vav
and Syk by Igb cross-linking on proB cells. The poor B (ERK, JNK/SAPK, and p38) in mammals, only ERK was
found to be activated by Igb stimulation. ERK has beencell generation from Vav-deficient embryonic stem cells
observed in RAG2/2 blastocyst complementation assays shown to play critical roles in both proliferation and
differentiation of the pheochromocytoma cell line PC12might be attributable at least in part to the lack of Vav
function in preBCR signaling (Fischer et al., 1995; Tara- stimulated by epidermal growth factor and nerve growth
factor, respectively (Traverse et al., 1992; Nguyen et al.,khovsky et al., 1995; Zhang et al., 1995). Since ample
evidence suggests the involvement of preBCR signaling 1993). Therefore, it would be reasonable to assume that
preBCR utilizes the ERK MAP kinase cascade for trans-in allelic exclusion in the heavy chain loci as well as in
the control of accessibility of Ig gene loci (Kitamura and ducing proliferation and/or differentiation signals. In this
regard, it is noteworthy that the MAP kinase cascadeRajewsky, 1992; Schlissel and Morrow, 1994; Grawun-
der et al., 1995; Loffert et al., 1996; Constantinescu and has recently been demonstrated to regulate early T cell
differentiation (Crompton et al., 1996). The cross-linkingSchlissel, 1997), it is intriguing to note that Vav has been
shown to be translocated to the nucleus and interact of CD3 on CD42CD82 thymocytes from RAG-1±deficient
mice activated ERK. The expression of dominant nega-with nuclear proteins such as heterogeneous ribo-
nucleoprotein K (hnRNP K), the DNA-binding compo- tive MAPKK1 (upstream activator of ERK) blocked the
differentiation from CD42CD82 to CD41CD81 thymocytesnent of DNA-dependent protein kinase (Ku-70) and
ENX-1 (Hobert et al., 1994, 1996; Romero et al., 1996). in fetal thymus organ cultures. In contrast, the constitu-
tively active MAPKK1 mutant failed to induce differentia-Similar to Vav, the SLP-76 adaptor protein with a SH2
domain is expressed specifically in hematopoietic cells tion of RAG-1±deficient thymocytes. These results sug-
gested that the MAP kinase cascade was necessary butand also becomes tyrosine-phosphorylated upon TCR
stimulation (Jackman et al., 1995). It has been shown not sufficient for the thymocyte differentiation induced
by preTCR stimulation. Since B and T cells utilize analo-that SLP-76 was themajor tyrosine-phosphorylated pro-
tein associated with Vav in stimulated T cells (Onodera gous formats such as the rearrangements of genes en-
coding antigen receptors and the formation of preBCR/et al., 1996; Tuosto et al., 1996; Wu et al., 1996), and that
the tyrosine kinase ZAP-70 phosphorylated SLP-76 at preTCR during their differentiation (reviewed by Borst
et al., 1996), it is not surprising that both precursor cellsspecific sites which allowed binding to the Vav SH2
domain (Raabet al., 1997). Based onthese observations, use the same signaling cascade.
together with our finding of SLP-76/Vav/Syk tyrosine-
phosphorylation in Igb-stimulated proB cells, one may
Surface Expression of the Iga/Igb Heterodimerassume that Syk plays a critical role in phosphorylation
in Association with Calnexinof Vav and SLP-76 and in their probable interaction in
We previously demonstrated that the VpreB/l5 surrogatethe preBCR signaling pathway. Though both Vav and
light chain was expressed on the surface of proB cellsSLP-76 are known to associate with an adaptor protein
in association with an unidentified 130 kDa glycoproteinGrb2 (Ramos-Morales et al., 1994; Ye and Baltimore,
(p130; Karasuyama et al., 1993). However, the VpreB/l5/1994; Jackman et al., 1995), we could not detect any
p130 complex was not coprecipitated with the Iga/Igbsignificant change in phosphorylation of Grb2 by Igb
heterodimer from the 38B9 proB cell line (Figure 2A;cross-linking on proB cells (unpublished observation).
Meffre et al., 1996), indicating that the vast majority ofThe catalytic subunit (p110) of PI3-kinase was identi-
the heterodimer is not associated with the surrogate lightfied as one of the major tyrosine-phosphorylated pro-
chain complex on proB cells. In accord with this, theteins in Igb-stimulated proB cells. This strongly suggests
cross-linking of surrogate light chain on RAG-22/2 proBthat PI3-kinase is a downstream effector of preBCR,
cells with specific MAbs induced little if any tyrosineconsistent with the previous report that cross-linking
phosphorylation of proteins in contrast to cross-linkingof preBCR on human preB cell lines induced tyrosine-
of the Iga/Igb complex (unpublished observation). Thephosphorylation and activation of PI3-kinase (Kuwahara
functional independence of these two complexes onet al., 1996). In mature B cells, cross-linking of BCR has
proB cells was further supported by the finding that thebeen shown toactivate PI3-kinase and induce its associ-
cross-linking of Igb on proB cells restored early B cellation with Lyn (Gold et al., 1992; Yamanashi et al., 1992;
development even in l5-deficient mice (unpublished ob-Pleiman et al., 1994a). It remains to be determined what
servation).kinase(s) associates with and phosphorylates PI3-kinase
Interestingly, the Iga/Igb heterodimer was found toand what molecules are downstream of PI3-kinase in
be in association with calnexin on the surface of proBthe preBCR signaling.
cells in the absence of preBCR and BCR. Calnexin is anWe found that ERK MAP kinase was tyrosine-phos-
integral membrane protein that functions as a molecularphorylated and activated in proB cells by Igb stimula-
chaperon to assist the folding and assembly of manytion. The activation was very rapid and peaked at 1 min
after the stimulation. This is the first report indicating nascent membrane and soluble proteins in the secretory
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pathway (Degen and Williams, 1991; Wada et al., 1991; binding of a putative ligand expressed on stromal cells
in bone marrow. Alternatively, preBCR may not requireHochstenbach et al., 1992; reviewed by Bergeron et al.,
1994). Calnexin is known to reside in the endoplasmic any extracellular ligand and may be constitutively acti-
vated through self-aggregation on the cell surface orreticulum (ER) through the retention motif (-RKPPRE) at
the C-terminus and retain incorrectly or incompletely within the cytoplasm (Aoki et al., 1994a, 1994b). In either
case, the in vivo and ex vivo system we have establishedfolded protein intermediates within ER (Rajagopalan et
al., 1994). Therefore, our finding of the surface expres- in the present study should help us to understand better
how the preBCR signaling governs B cell development.sion of calnexin in association with the Iga/Igb hetero-
dimer is remarkable. In this regard, it is notable that
immature CD42CD82 thymocytes were recently found Experimental Procedures
to express calnexin on their surface in association with
Micethe CD3 complex (Wiest et al., 1994, 1995, 1997). This
RAG-2±deficient mice (Shinkai et al., 1992), kindly provided by Dr.escape of calnexin/CD3 complexes to the cell surface
F. W. Alt (HHMI, the Children's Hospital, Boston, MA), were bred
was shown to be a consequence of cytoplasmic domain and maintained under specific pathogen-free (SPF) conditions in
interactions between calnexin and CD3e chains that our animal facility and used for analysis at 10±13 weeks of age. RAG-
could presumably interfere with recognition of calnexin 2±deficient mice with m heavy chain transgene were established by
mating betweenRAG-2±deficient mice and T15i m heavy chain gene-by ER retention receptors (Wiest et al., 1995). Thus, the
knock-in mice (Taki et al., 1993).incomplete ER retention of calnexin appears to be a
common feature of both B and T early precursor cells,
Cell Lineseven though its physiological meaning in early lympho-
63-12 (proB cell line derived from fetal liver of RAG-2±deficient mice;
cyte development remains to be determined. Shinkai et al., 1992), 38B9 (proB cell line derived from fetal liver of
In Igb-deficient mice, B cell development was com- BALB/c mice; Alt et al., 1981), and NFS5.3 (preB cell line derived from
NFS/N mice; Hardy et al., 1986) cells were maintained in Iscove'spletely blocked at the proB cell stage, confirming the
modified Dulbecco's medium (IMDM) supplemented with 10% fetalessential role of Igb as a signal transducer of the preBCR
calf serum (FCS), 100 U/ml of penicillin-streptomycin, 2 mM L-gluta-(Gong and Nussenzweig, 1996). Intriguingly, thedetailed
mine, and 50 mM 2-mercaptoethanol. WEHI231 cells (immature Banalysis of Ig gene assembly in proB cells from these
cell line; Warner et al., 1979) were maintained in RPMI 1640 medium
mice revealed that the level of VH to DHJH rearrangements supplemented as for IMDM medium.
was severely diminished in contrast to the normal levels
of DH to JH joining. However, in mice with disrupted Antibodies
Fluorescein isothiocyanate (FITC)- or phycoerythrin (PE)-conjugatedtransmembrane domain of m heavy chain, developmen-
anti-CD45R (B220), FITC-conjugated anti-CD8 MAbs, and biotin-tally arrested proB cells were shown to accumulate nor-
conjugated MAbs specific to CD25 (Tac), BP-1, CD43 (S7), IgM (mmal number of VH to DHJH joints despite the absence
heavy chain), CD4, and control MAb (rat IgG2a) were purchasedof functional preBCR (Ehlich et al., 1993). These results
from Pharmingen (San Diego, CA). Antibodies specific to PI3-kinase
indicated the possibility that the Igb might function even (p110), Vav, Syk, Grb2, ERK-1, JNK-1, and p38 were from Santa
prior to the expression of preBCR and make cells com- Cruz Biotech. Inc. (Santa Cruz, CA). Biotin- and agarose-conjugated
anti-phosphotyrosine MAb (4G10) were from Upstate Biotechnologypetent to undergo VH-DHJH rearrangement. Our finding
Inc. (Lake Placid, NY). The MAbs specific to l5 (LM34; Karasuyamathat Igb on the surface of normal proB cells is competent
et al., 1993), c-kit (ACK-4; Nishikawa et al., 1988), and CD2 (RM2-2;to transduce signals appears compatible with this possi-
Yagita et al., 1989) were conjugated with biotin by standard meth-bility. One may assume that the binding of a putative
ods. The antisera against calnexin (Wada et al., 1991), SLP-76 (Jack-
ligand to the Iga/Igb/calnexin complex or the assembly man et al., 1995), and Iga (Pleiman et al., 1994b) were kindly provided
of the complex itself transduces a signal(s) to make proB by Dr. I. Wada (Sapporo Medical College, Sapporo), Dr. G. A. Koret-
zky (University of Iowa, IA), and Dr. J. Jongstra (The Toronto Hospitalcells competent to undergo VH-DHJH rearrangement un-
Research Institute, Toronto, Canada), respectively. The MAb againstder physiological conditions, whereas the signals forc-
CD3e (2C11) was described previously (Leo et al., 1987). Establish-ibly delivered by cross-linking with the antibody mimic
ment and characterization of HM79, a hamster MAb against mousepreBCR signals and induce differentiation of the proB
Igb, was described previously (Koyama et al., 1997).
cells to small preB cells as demonstrated in this study.
In Vivo Injection of Antibodies
RAG-2±deficient mice (10±13 weeks old) were treated with either
Conclusions anti-Igb MAb (HM79) or anti-CD3e MAb (2C11). One milligram of
antibody in 1 ml of phosphate-buffered saline (PBS) was injected
intraperitoneally, and mice were sacrificed 4, 6, 8, 10, or 12 daysThe present study has demonstrated that the Iga/Igb
post-injection for analysis.complex on proB cells is competent for transducing
signals to phosphorylate and/or activate nonreceptor
Flow Cytometric Analysistype kinases including Syk, ERK, and PI3-kinase as well
For the staining of bone marrow cells, single-cell suspensions from
as a number of signaling modules such as Vav and SLP- bone marrow were prepared by injecting 5% FCS/PBS buffer into
76. The involvement of these molecules in the signal femurs and tibias to flush out cells, gently pipetted, and washed
twice with staining buffer (PBS containing 0.1% bovine serum albu-transduction through preBCR is strongly suggested by
min (BSA) and 0.1% NaN3). The cells were then pretreated with 10%the finding that the Igb cross-linking on bone marrow
heat-inactivated normal rat serum for 30 min on ice. For the stainingproB cells in vivo induced early B cell differentiation
of thymocytes and cell lines, cells were preincubated with Fc blockindistinguishable from that mediated by preBCR in nor-
reagent (Pharmingen) for 10 min on ice. Subsequently, cells were
mal B cell development. It remains to be determined incubated with FITC- and biotin-conjugated MAbs for 30 min on
what triggers this Iga/Igb-mediated preBCR signaling ice. The cells were then incubated for 15 min with PE-conjugated
streptavidin (SA) to reveal the biotinylated reagents. Before andcascade under physiological conditions. It might be the
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after each step of incubation, cells werewashed with staining buffer. The Basel Institute for Immunology was founded and is supported
by F. Hoffmann-La Roche Limited Company, Basel, Switzerland.For cytoplasmic staining, cells were fixed with 0.25% paraformalde-
hyde in PBS at 48C overnight and then permeabilized with 0.2%
Tween 20 in PBS at room temperature for 15 min. Permeabilized Received June 23, 1997; revised August 20, 1997.
cells were incubated with biotin-conjugated anti-Igb and then with
Cy-Chrome-conjugated SA to reveal the biotinylated reagent.
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